AtaGenix

Hot search： CD47 │ IL6 │ PD-L1 │ CTLA-4 │ TIGIT
Current Site： Product Center / 2019-nCoV products / 2019-nCoV Antibody / Anti 2019-nCoV S Protein RBD polyclonal antibody

Anti 2019-nCoV S Protein RBD polyclonal antibody

  • 1
ATP247
-
+
Spot
Inquiry
  • Product Details
  • References
  • How to order
  • Instructions
Summaryicon
Product name
Anti 2019-nCoV S Protein RBD polyclonal antibody
Catalog#
ATP247
description

Produced in mouse immunized with purified,Recombinant SARS-CoV-2 S Protein RBD

Accession #
P0DTC2
Alternative names
S glycoprotein,E2,Peplomer protein,Spike protein S1
Stability &Storage
Use a manual defrost freezer and avoid repeated freeze thaw cycles.
Store at 2 to 8 °C for one week .
Store at -20 to -80 °C for twelve months from the date of receipt.
Spcificity
Recognizes SARS-CoV-2 S Protein RBD
Isotype
IgG
Host
Mouse
Clonality
Polyclonal
Conjugation
Unconjugate
Species reactivity
Severe acute respiratory syndrome coronavirus 2 (2019-nCoV) (SARS-CoV-2)
Tested applications
Elisa
Immunogen
Recombinant SARS-CoV-2 S Protein RBD(Thr333-Pro527)
Backgroundicon
Protein S (PROS1) is glycoprotein and expressed in many cell types supporting its reported involvement in multiple biological processes that include coagulation, apoptosis, cancer development and progression, and the innate immune response. Known receptors bind S1 are ACE2, angiotensin-converting enzyme 2, DPP4, CEACAM etc.. The spike (S) glycoprotein of coronaviruses is known to be essential in the binding of the virus to the host cell at the advent of the infection process. Most notable is severe acute respiratory syndrome (SARS). The severe acute respiratory syndrome-coronavirus (SARS-CoV) spike (S) glycoprotein alone can mediate the membrane fusion required for virus entry and cell fusion. It is also a major immunogen and a target for entry inhibitors. It's been reported that 2019-nCoV can infect the human respiratory epithelial cells through interaction with the human ACE2 receptor. The spike protein is a large type I transmembrane protein containing two subunits, S1 and S2. S1 mainly contains a receptor binding domain (RBD), which is responsible for recognizing the cell surface receptor. S2 contains basic elements needed for the membrane fusion.The S protein plays key parts in the induction of neutralizing-antibody and T-cell responses, as well as protective immunity.
Product performanceicon
Form
Liquid
Buffer
PBS, pH7.4, containing 0.05% proclin300, 50% glycerol.
Concentration
0.478mg/ml
MW
141kDa
Applicationicon
Dilution Range
Elisa:1:4000~1:8000
Noteicon
For research use only.
PubMed:32142651, PubMed:32075877, PubMed:32155444, PubMed:32362314

Guarantee and Disclaimer:

After receiving the product, if finds that the product is mismatched, damaged or missing components, please keep the original package and submit the objection to the company by mail within seven working days. Failure to file an objection within the time limit is considered qualified.

When the buyer keeps the product, it should be kept in accordance with the storage conditions shown in the product label and the manual. If the product quality is caused by improper storage, it will not be guaranteed.

When the buyer tests the product, they should be submitted by the beginning of use when found the quality issue, rather than when the product was used or used up, in order to prepare our products for recycling and confirm the quality of the products. If it is the quality problem, our company is responsible for exchange or return. In the event of a claim, our company will compensate the discretion within the scope of the product price limit and will not accept any part of the value of the product itself. Since the date of receipt, the product has not been reflected for more than three months and should not be returned.

The products provided by our company are for research use only and should not be used for clinical diagnosis or treatment. If a unit or individual changes the use of our products without authorization, we will not bear any responsibility.

AtaGenix
Copyright © 2024 Lawyer Theme All Rights Reserved
Site map | Contact us | Join us